Coronavirus Disease-2019 in the Immunocompromised Host.

COVID-19 Hematologic malignancy Immunocompromised host Immunosuppression Pneumonia SARS-CoV-2

Journal

Clinics in chest medicine
ISSN: 1557-8216
Titre abrégé: Clin Chest Med
Pays: United States
ID NLM: 7907612

Informations de publication

Date de publication:
06 2023
Historique:
medline: 25 4 2023
pubmed: 22 4 2023
entrez: 21 04 2023
Statut: ppublish

Résumé

Immunocompromised hosts, which encompass a diverse population of persons with malignancies, human immunodeficiency virus disease, solid organ, and hematologic transplants, autoimmune diseases, and primary immunodeficiencies, bear a significant burden of the morbidity and mortality due to coronavirus disease-2019 (COVID-19). Immunocompromised patients who develop COVID-19 have a more severe illness, higher hospitalization rates, and higher mortality rates than immunocompetent patients. There are no well-defined treatment strategies that are specific to immunocompromised patients and vaccines, monoclonal antibodies, and convalescent plasma are variably effective. This review focuses on the specific impact of COVID-19 in immunocompromised patients and the gaps in knowledge that require further study.

Identifiants

pubmed: 37085228
pii: S0272-5231(22)00128-9
doi: 10.1016/j.ccm.2022.11.012
pmc: PMC9678818
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

395-406

Informations de copyright

Copyright © 2022 Elsevier Inc. All rights reserved.

Références

Cancer Discov. 2020 Jun;10(6):783-791
pubmed: 32345594
Sci Rep. 2022 Jan 12;12(1):638
pubmed: 35022495
Nat Commun. 2022 Mar 17;13(1):1547
pubmed: 35301314
Blood Adv. 2022 Sep 27;6(18):5307-5316
pubmed: 35446933
Blood. 2021 Nov 4;138(18):1768-1773
pubmed: 34297826
Nephrol Dial Transplant. 2020 Nov 1;35(11):1973-1983
pubmed: 33151337
Infect Dis (Lond). 2022 Apr;54(4):283-291
pubmed: 34878955
Leukemia. 2022 Apr;36(4):1025-1034
pubmed: 35105946
JAMA. 2016 Dec 20;316(23):2547-2548
pubmed: 27792809
J Clin Med. 2021 Aug 15;10(16):
pubmed: 34441891
Curr Probl Cancer Case Rep. 2021 Mar;3:100057
pubmed: 34308401
Am J Transplant. 2020 Nov;20(11):3051-3060
pubmed: 32654332
Sci Immunol. 2020 Jul 10;5(49):
pubmed: 32651212
Blood. 2020 Sep 3;136(10):1134-1143
pubmed: 32688395
Ann Oncol. 2020 Oct;31(10):1386-1396
pubmed: 32561401
Nat Commun. 2021 Nov 4;12(1):6405
pubmed: 34737266
Oncologist. 2021 Sep;26(9):e1656-e1659
pubmed: 34028132
Lancet Infect Dis. 2022 Apr;22(4):e102-e107
pubmed: 34951953
J Allergy Clin Immunol. 2020 Jul;146(1):211-213.e4
pubmed: 32333914
Rheumatology (Oxford). 2021 Oct 9;60(SI):SI59-SI67
pubmed: 33369663
Ann Rheum Dis. 2022 Jun 14;:
pubmed: 35701154
N Engl J Med. 2022 Jan 27;386(4):305-315
pubmed: 34937145
J Allergy Clin Immunol. 2010 Feb;125(2 Suppl 2):S195-203
pubmed: 20042227
Lancet Oncol. 2020 Jul;21(7):893-903
pubmed: 32479790
Transplantation. 2022 Mar 1;106(3):436-446
pubmed: 34982758
Int J Infect Dis. 2021 Mar;104:379-381
pubmed: 33359065
Cancer Discov. 2022 Jan;12(1):62-73
pubmed: 34753749
Blood. 2015 Jun 11;125(24):3789-97
pubmed: 25918347
JAMA Intern Med. 2022 Feb 1;182(2):115-126
pubmed: 34901997
BMJ Open. 2021 Oct 25;11(10):e052777
pubmed: 34697120
Ann Rheum Dis. 2020 Sep;79(9):1156-1162
pubmed: 32457048
Cancer Discov. 2020 Jul;10(7):935-941
pubmed: 32357994
Viruses. 2022 Apr 01;14(4):
pubmed: 35458476
Immunol Allergy Clin North Am. 2015 Nov;35(4):599-623
pubmed: 26454309
Gastroenterology. 2020 Aug;159(2):481-491.e3
pubmed: 32425234
Ann Rheum Dis. 2021 Oct;80(10):1345-1350
pubmed: 34285048
N Engl J Med. 2021 Mar 4;384(9):795-807
pubmed: 33306283
J Clin Oncol. 2022 May 1;40(13):1414-1427
pubmed: 35286152
PLoS One. 2021 Oct 1;16(10):e0257641
pubmed: 34597325
J Crit Care. 2018 Dec;48:172-177
pubmed: 30216935
Lancet Oncol. 2021 Dec;22(12):1669-1680
pubmed: 34741822
Am J Transplant. 2020 Nov;20(11):3182-3190
pubmed: 32654422
Front Immunol. 2022 Mar 22;13:858399
pubmed: 35401575
Clin Infect Dis. 2022 May 3;74(9):1515-1524
pubmed: 34358310
Leukemia. 2021 Oct;35(10):2885-2894
pubmed: 34079042
Cancer Cell. 2022 Jul 11;40(7):738-753.e5
pubmed: 35679859
N Engl J Med. 2022 Apr 14;386(15):1397-1408
pubmed: 35172054
Proc Natl Acad Sci U S A. 2021 Feb 23;118(8):
pubmed: 33536313
Clin Microbiol Infect. 2021 Nov;27(11):1652-1657
pubmed: 34245907
J Intensive Care. 2020 Jul 10;8:49
pubmed: 32665858
J Infect Dis. 2021 Jan 4;223(1):23-27
pubmed: 33089317
Ann Oncol. 2022 Mar;33(3):340-346
pubmed: 34958894
Am J Hematol. 2021 Aug 1;96(8):934-944
pubmed: 33909916
Clin Transplant. 2022 Jan;36(1):e14492
pubmed: 34558116
Turk J Med Sci. 2021 Apr 21;51(4):1647-1652
pubmed: 33878857
JAMA Oncol. 2022 Jul 1;8(7):1027-1034
pubmed: 35394485
Am J Transplant. 2020 Nov;20(11):3140-3148
pubmed: 32649791
N Engl J Med. 2020 Dec 3;383(23):2291-2293
pubmed: 33176080
Clin Immunol. 2020 Aug;217:108486
pubmed: 32479985
Intensive Care Med. 2017 Dec;43(12):1808-1819
pubmed: 28948369
AIDS. 2020 Nov 1;34(13):1983-1985
pubmed: 32796214
Science. 2020 Aug 7;369(6504):718-724
pubmed: 32661059
Transplantation. 2021 Jan 1;105(1):177-186
pubmed: 33141808
J Hosp Infect. 2021 May;111:202-204
pubmed: 33631234
J Hematol Oncol. 2021 Oct 14;14(1):168
pubmed: 34649563
Ann Intern Med. 2020 Oct 6;173(7):536-541
pubmed: 32589451

Auteurs

Christopher D Bertini (CD)

Department of Internal Medicine, UTHealth Houston McGovern Medical School, 6431 Fannin, MSB 1.150, Houston, TX 77030, USA.

Fareed Khawaja (F)

Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1469, Houston, TX 77030, USA.

Ajay Sheshadri (A)

Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, 1400 Pressler Street Unit 1462, Houston, TX 77030, USA. Electronic address: asheshadri@mdanderson.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH